Compositions for progeny gender control

Details for Australian Patent Application No. 2005237290 (hide)

Owner AQ+ Plc

Inventors Taylor, Russell

Agent Halford & Co

Pub. Number AU-A-2005237290

PCT Pub. Number WO2005/105090

Priority 0409725.9 04.05.04 GB

Filing date 3 May 2005

Wipo publication date 10 November 2005

International Classifications

A61K 31/522 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61K 31/47 (2006.01) - Quinolines

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/105090 Priority application(s): WO2005/105090

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237301-Morpholine compounds

2005237289-Meningococcal conjugate vaccination